As the global economy recovers in 2021 and the supply of the industrial chain improves, the Clinical Biomarkers market will undergo major changes. According to the latest research, the market size of the Clinical Biomarkers industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Clinical Biomarkers industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Clinical Biomarkers market during the next few years. The global Clinical Biomarkers market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The Clinical Biomarkers market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Player list
Abbott Laboratories
Agilent Technologies, Inc.
ALCEDIAG
Becton, Dickinson and Company
bioMrieux S.A.
Bio-Rad Laboratories, Inc.
CENTOGENE N.V.
F. Hoffmann-La Roche Ltd.
Enzo Biochem Inc.
Illumina, Inc.
Myriad Genetics, Inc.
Quest Diagnostics Incorporated
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Types list
Diagnostic Biomarkers
Predictive Biomarkers
Prognostic Biomarkers
Application list
Research and Academic Laboratories
Biopharmaceutical and Biotech Companies
Diagnostic Centers
Others